Patient and disease characteristics in invasive primary epithelial ovarian cancers (n = 82)
. | . | N . | Percentage . |
---|---|---|---|
Age | |||
Median | 56 | ||
Range | 34–82 | ||
Stage | |||
FIGO I | 12 | 14.6 | |
FIGO II | 6 | 7.3 | |
FIGO III | 50 | 61.0 | |
FIGO IV | 14 | 17.1 | |
Histology | |||
Serous | 53 | 64.6 | |
Mucinous | 10 | 12.2 | |
Endometroid | 15 | 18.3 | |
Undifferentiated | 3 | 3.7 | |
Clear cell | 1 | 1.2 | |
Grading | |||
G1 | 8 | 9.8 | |
G2 | 28 | 34.1 | |
G3 | 42 | 51.2 | |
G4 | 4 | 4.9 | |
Hormone receptor status (n = 70) | |||
ER-negative | 27 | 38.6 | |
ER-positive | 43 | 61.4 | |
PR-negative | 41 | 57.1 | |
PR-positive | 29 | 42.9 | |
uPA | |||
≤5.5 | 64 | 78.0 | |
>5.5 | 18 | 22.0 | |
PAI-1 | |||
≤18.8 | 41 | 50 | |
>18.8 | 41 | 50 |
. | . | N . | Percentage . |
---|---|---|---|
Age | |||
Median | 56 | ||
Range | 34–82 | ||
Stage | |||
FIGO I | 12 | 14.6 | |
FIGO II | 6 | 7.3 | |
FIGO III | 50 | 61.0 | |
FIGO IV | 14 | 17.1 | |
Histology | |||
Serous | 53 | 64.6 | |
Mucinous | 10 | 12.2 | |
Endometroid | 15 | 18.3 | |
Undifferentiated | 3 | 3.7 | |
Clear cell | 1 | 1.2 | |
Grading | |||
G1 | 8 | 9.8 | |
G2 | 28 | 34.1 | |
G3 | 42 | 51.2 | |
G4 | 4 | 4.9 | |
Hormone receptor status (n = 70) | |||
ER-negative | 27 | 38.6 | |
ER-positive | 43 | 61.4 | |
PR-negative | 41 | 57.1 | |
PR-positive | 29 | 42.9 | |
uPA | |||
≤5.5 | 64 | 78.0 | |
>5.5 | 18 | 22.0 | |
PAI-1 | |||
≤18.8 | 41 | 50 | |
>18.8 | 41 | 50 |